Voices
Noelia Tarazona
Photo: Noelia Tarazona/incliva.es

Noelia Tarazona: ESMO Open – Tumor Boards Improve Outcomes with Matched Therapies for ESCAT II–III Alterations

Noelia Tarazona, Research Fellow at Mass General Brigham Cancer Center, shared on X about a recent paper by V. Seguí et al. published on ESMO Open:

“New in ESMO Open: Tumor Boards can guide matched therapies for ESCAT II-III alterations. Patients had median OS 31 vs 11 months. Study conducted at INCLIVA, GVA Sanitat, led by Desam Roda, Valentina Gambardella.”

Title: Enhancing precision oncology: the role of molecular tumor boards in early identification and targeted treatment of ESCAT II-III alterations

Authors: V. Seguí, J.A. Carbonell-Asins, J. Martín-Arana, M. García-Bartolomé, N. Grimalt, C. Martinez-Ciarpaglini, J.F. Gonzalez-Muñoz, P. Martín-Martorell, I. Gonzalez-Barrallo, A. Viala, M. Tapia, M. Huerta, G. Bruixola, A. Insa, J.M. Cejalvo, T. Fleitas, N. Tarazona, A. Cervantes, D. Roda, V. Gambardella

Read the full article.

Noelia Tarazona

More insights from Noelia Tarazona.

A. Cervantes A. Insa A. Viala C. Martínez-Ciarpaglini cancer D. Roda Desam Roda G. Bruixola I. Gonzalez-Barrallo J. Martín-Arana J.A. Carbonell-Asins J.F. Gonzalez-Muñoz J.M. Cejalvo M. García-Bartolomé M. Huerta M. Tapia N. Grimalt N. Tarazona Noelia Tarazona OncoDaily Oncology P. Martín-Martorell T. Fleitas V. Gambardella V. Seguí Valentina Gambardella